Literature DB >> 22986822

Comments on O'Brien et al.: prevalence and outcome of cirrhosis patients admitted to UK intensive care: a comparison against dialysis-dependent chronic renal failure patients.

Nicholas P Mason, Andrew D Yeoman.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22986822     DOI： 10.1007/s00134-012-2703-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

Review 1.  Dialysis patients and critical illness.

Authors:  Stephanie Thompson; Neesh Pannu
Journal:  Am J Kidney Dis       Date:  2011-11-05       Impact factor: 8.860

Review 2.  Review article: scoring systems for assessing prognosis in critically ill adult cirrhotics.

Authors:  E Cholongitas; M Senzolo; D Patch; S Shaw; C Hui; A K Burroughs
Journal:  Aliment Pharmacol Ther       Date:  2006-08-01       Impact factor: 8.171

3.  Prevalence and outcome of cirrhosis patients admitted to UK intensive care: a comparison against dialysis-dependent chronic renal failure patients.

Authors:  Alastair J O'Brien; Cathy A Welch; Mervyn Singer; David A Harrison
Journal:  Intensive Care Med       Date:  2012-03-29       Impact factor: 17.440

4.  Improved survival after variceal bleeding in patients with cirrhosis over the past two decades.

Authors:  Nicolas Carbonell; Arnaud Pauwels; Lawrence Serfaty; Olivier Fourdan; Victor George Lévy; Raoul Poupon
Journal:  Hepatology       Date:  2004-09       Impact factor: 17.425

Review 5.  The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis.

Authors:  Mitchell M Levy; R Phillip Dellinger; Sean R Townsend; Walter T Linde-Zwirble; John C Marshall; Julian Bion; Christa Schorr; Antonio Artigas; Graham Ramsay; Richard Beale; Margaret M Parker; Herwig Gerlach; Konrad Reinhart; Eliezer Silva; Maurene Harvey; Susan Regan; Derek C Angus
Journal:  Intensive Care Med       Date:  2010-01-13       Impact factor: 17.440
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.